Viralytics
Sydney · Founded 2006
About Viralytics
Viralytics is an Australian biotechnology company, listed on the Australian Stock Exchange (ASX:VLA) and is quoted on the OTC market (VRACY). Focused on developing oncolytic virotherapy for the treatment of a wide range of cancers Viralytics' headquarters are in Sydney, Australia and research and operations are in Newcastle, Australia. Oncolytic virotherapy makes use of the cancer destroying capabilities of a range of benign viruses. The potential of oncolytic virotherapy is the ability to treat cancers more effectively and with minimum side-effects.
Company Facts
- Founded: 2006
- Legal name: Viralytics Limited
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $27.0M
- Funding stage: M&A
- Last round: Post-IPO Equity (Mar 2014)
- Website: viralytics.com
- Phone: +61 2 9988 4000
Social Profiles
Canonical: https://fsome.com/organization/viralytics-8460890 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.